An open-label safety study to evaluate the use of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) [lidocaine/tetracaine] in adult patients undergoing a minor or major dermal procedure

Trial Profile

An open-label safety study to evaluate the use of S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) [lidocaine/tetracaine] in adult patients undergoing a minor or major dermal procedure

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs Lidocaine/tetracaine (Primary)
  • Indications Procedural pain
  • Focus Adverse reactions
  • Sponsors ZARS Pharma
  • Most Recent Events

    • 12 Jun 2012 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 05 Jun 2012 Actual patient number is 408 according to ClinicalTrials.gov.
    • 05 Jun 2012 Actual end date (Sep 2005) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top